Literature DB >> 32785703

Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.

Xinhuan Su1,2,3,4,5,6, Xianlun Yin3,4,5, Yue Liu1,2,3,4,5,6, Xuefang Yan3,4,5, Shucui Zhang3,4,5, Xiaowei Wang3,4,5, Zongwei Lin3,4,5, Xiaoming Zhou1,2, Jing Gao3,4,5, Zhe Wang1,2,6, Qunye Zhang3,4,5.   

Abstract

BACKGROUND: Graves' disease (GD) is a typical organ-specific autoimmune disease. Intestinal flora plays a pivotal role in immune homeostasis and autoimmune disease development. However, the association and mechanism between intestinal flora and GD remain elusive.
OBJECTIVE: To investigate the association and mechanism between intestinal flora and GD.
METHODS: We recruited 58 initially untreated GD patients and 63 healthy individuals in the study. The composition and metabolic characteristics of the intestinal flora in GD patients and the causal relationship between intestinal flora and GD pathogenesis were assessed using 16S rRNA gene sequencing, targeted/untargeted metabolomics, and fecal microbiota transplantation.
RESULTS: The composition, metabolism, and inter-relationships of the intestinal flora were also changed, particularly the significantly reduced short-chain fatty acid (SCFA)-producing bacteria and SCFAs. The YCH46 strain of Bacteroides fragilis could produce propionic acid and increase Treg cell numbers while decreasing Th17 cell numbers. Transplanting the intestinal flora of GD patients significantly increased GD incidence in the GD mouse model. Additionally, there were 3 intestinal bacteria genera (Bacteroides, Alistipes, Prevotella) could distinguish GD patients from healthy individuals with 85% accuracy.
CONCLUSIONS: Gut dysbiosis contributes to a Treg/Th17 imbalance through the pathway regulated by propionic acid and promotes the occurrence of GD, together with other pathogenic factors. Bacteroides, Alistipes, and Prevotella have great potential to serve as adjunct markers for GD diagnosis. This study provided valuable clues for improving immune dysfunction of GD patients using B. fragilis and illuminated the prospects of microecological therapy for GD as an adjunct treatment. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Bacteroides fragiliszzm321990 ; Graves’ disease; Treg/Th17; intestinal flora; propionic acid

Year:  2020        PMID: 32785703     DOI: 10.1210/clinem/dgaa511

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.

Authors:  Sijie Fang; Yi Lu; Yazhuo Huang; Huifang Zhou; Xianqun Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

Review 2.  The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.

Authors:  Jueyu Hou; Yunjing Tang; Yongjiang Chen; Danian Chen
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

3.  Identification of lncRNA and mRNA Expression Profile in Relapsed Graves' Disease.

Authors:  Qiuming Yao; Zhenyu Song; Bin Wang; Xi Jia; Ronghua Song; Jinan Zhang
Journal:  Front Cell Dev Biol       Date:  2021-12-01

Review 4.  Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease.

Authors:  Haihua Liu; Huiying Liu; Chang Liu; Mengxue Shang; Tianfu Wei; Peiyuan Yin
Journal:  Front Mol Biosci       Date:  2022-02-16

5.  A Comprehensive Analysis of the Colonic Flora Diversity, Short Chain Fatty Acid Metabolism, Transcripts, and Biochemical Indexes in Heat-Stressed Pigs.

Authors:  Canying Hu; Xueting Niu; Shengwei Chen; Jiaying Wen; Minglong Bao; Sahar Ghulam Mohyuddin; Yanhong Yong; Xiaoxi Liu; Lianyun Wu; Zhichao Yu; Xinbin Ma; Xianghong Ju
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

6.  Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves' Disease Before and After Methimazole Treatment.

Authors:  Mengxue Yang; Xiaodi Zheng; Yueyue Wu; Rui Zhang; Qian Yang; Zhiyan Yu; Jun Liu; Bingbing Zha; Qihai Gong; Bo Yang; Bowen Sun; Miao Zeng
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

Review 7.  Best Achievements in Translational and Basic Thyroidology in 2020.

Authors:  Sun Wook Cho; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24

Review 8.  Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.

Authors:  Fangyu Zhou; Xin Wang; Lingjun Wang; Xin Sun; Guiqin Tan; Wenwen Wei; Guangbing Zheng; Xiaomin Ma; Dan Tian; Hongsong Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-04

Review 9.  Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy.

Authors:  Yan Wang; Xiao-Min Ma; Xin Wang; Xin Sun; Ling-Jun Wang; Xin-Qi Li; Xiao-Yan Liu; Hong-Song Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-05       Impact factor: 5.555

10.  Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis.

Authors:  Shuting Wen; Long He; Zhuotai Zhong; Runyuan Zhao; Senhui Weng; Hong Mi; Fengbin Liu
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.